These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 6415629
1. Gonadotropin-releasing hormone agonistic analogues in the treatment of advanced prostatic carcinoma. Koutsilieris M, Tolis G. Prostate; 1983; 4(6):569-77. PubMed ID: 6415629 [Abstract] [Full Text] [Related]
2. Advanced prostatic adenocarcinoma: biological aspects and effects of androgen deprivation achieved by castration or agonistic analogues of LHRH. Tolis G, Koutsilieris M, Herrera R, Stellos A, Martinez A, Dufresne M. Med Oncol Tumor Pharmacother; 1984; 1(2):129-36. PubMed ID: 6443576 [Abstract] [Full Text] [Related]
3. Transabdominal ultrasonography in the evaluation of patients with advanced prostatic carcinoma: effects of castration and of chronic administration of a gonadotropin releasing hormone agonistic analogue. Tolis G, Koutsilieris M, Fazekas AT, Patton R. Prostate; 1983; 4(6):595-600. PubMed ID: 6415631 [Abstract] [Full Text] [Related]
4. Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists. Tolis G, Ackman D, Stellos A, Mehta A, Labrie F, Fazekas AT, Comaru-Schally AM, Schally AV. Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1658-62. PubMed ID: 6461861 [Abstract] [Full Text] [Related]
5. [New approach in the treatment of prostatic cancer: combined use of a LHRH agonist and an androgen antagonist]. Labrie F, Dupont A, Belanger A, Lefebvre FA, Raynaud JP. J Pharmacol; 1983 Mar; 14 Suppl 3():117-35. PubMed ID: 6423907 [Abstract] [Full Text] [Related]
6. Preliminary results on the clinical efficacy and safety of androgen inhibition by an LHRH agonist alone or combined with an antiandrogen in the treatment of prostatic carcinoma. Faure N, Lemay A, Laroche B, Robert G, Plante R, Jean C, Thabet M, Roy R, Fazekas AT. Prostate; 1983 Mar; 4(6):601-24. PubMed ID: 6415632 [Abstract] [Full Text] [Related]
18. Long-term endocrine profiles of prostatic carcinoma patients under pernasal as well as intramuscular Gn-RH analogue treatment. Wenderoth UK, Jacobi GH. Prog Clin Biol Res; 1985 Mar; 185A():297-305. PubMed ID: 3162176 [Abstract] [Full Text] [Related]
19. Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue. Huhtaniemi I, Nikula H, Rannikko S. J Clin Endocrinol Metab; 1985 Oct; 61(4):698-704. PubMed ID: 2993345 [Abstract] [Full Text] [Related]